|
|
| Ensuring The Efficacy Of Probiotic Products | Article | Ropack Pharma Solutions | Without proper handling and packaging, the efficacy of probiotics can be compromised at any point in the packaging, storage, and transportation process, impacting shelf life and effectiveness. |
|
|
|
| What Is Aseptic Processing? | Article | Cytiva | Aseptic processing sterilizes products and packaging separately, then combines them in a sterile environment. See how this ensures safety, extends shelf life, and protects from contamination. |
|
|
|
|
By Wilhelm van Zyl, Veltrion Laboratories | The wrong regulatory filing sequence can close faster pathways, delay importation, and consume shelf life. Here’s how regulatory strategy can reshape clinical supply. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity | Application Note | By Stephan Koza, Stephen Shiner, and Matthew Lauber, Waters Corporation | Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis. |
|
|
|
| ddPCR Workflows For Gene Expression Analysis | Application Note | Bio-Rad Laboratories, Inc. | RT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Find out how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies. |
|
|
|
|
| How To Handle Intrinsic Product Powder Particles | Article | Dalton Pharma Services | Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements. |
|
|
|
| GLP-1 INJ Solid Phase Peptide Synthesis (SPPS) Workflow | Poster | ILC Dover, An Ingersoll Rand Business | Scale your GLP-1 peptide synthesis efficiently. Gain insight into how automated solid-phase workflows and single-use fluidics maximize crude purity while reducing total solvent consumption. |
|
|
|
|
| What Your Biological Indicator Strategy Might Be Missing | Article | By Lloyd Rowe, Protak Scientific Ltd | While biological indicators have long been the industry standard for evaluating bio-decontamination cycles, faster, cheaper, and quantifiable contamination detection technologies are emerging. |
|
|
| Chemoenzymatic N-glycan Conjugation Of Native mAbs | White Paper | By Remon van Geel, Marloes A. Wijdeven, Ryan Heesbeen, et al., Lonza | A chemoenzymatic two-stage protocol enables DAR2 ADCs from native mAbs via glycan remodeling at Asn-297 and copper-free click chemistry, with in vivo efficacy outperforming a comparable ADC. |
|
|
| Robust Database Characterizes And Optimizes Product Development | White Paper | By Karin Marek, Maximilian Fuchs, Dr. Elke Sternberger-Rützel, Harro Höfliger | Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance. |
|
|
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|